Invention Grant
- Patent Title: Sustained polypeptide expression from synthetic, modified RNAs and uses thereof
-
Application No.: US15692518Application Date: 2017-08-31
-
Publication No.: US10344265B2Publication Date: 2019-07-09
- Inventor: Derrick Rossi , Luigi Warren
- Applicant: Children's Medical Center Corporation
- Applicant Address: US MA Boston
- Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Agent David S. Resnick
- Main IPC: C12N15/00
- IPC: C12N15/00 ; C12N5/074 ; C12N15/11 ; C07K14/435 ; C12N5/00

Abstract:
Described herein are synthetic, modified RNAs for changing the phenotype of a cell, such as expressing a polypeptide or altering the developmental potential. Accordingly, provided herein are compositions, methods, and kits comprising synthetic, modified RNAs for changing the phenotype of a cell or cells. These methods, compositions, and kits comprising synthetic, modified RNAs can be used either to express a desired protein in a cell or tissue, or to change the differentiated phenotype of a cell to that of another, desired cell type.
Public/Granted literature
- US20180216078A1 SUSTAINED POLYPEPTIDE EXPRESSION FROM SYNTHETIC, MODIFIED RNAS AND USES THEREOF Public/Granted day:2018-08-02
Information query
IPC分类: